Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: US TERM Act is "blunt instrument"; SPC waiver prep begins; China patent amendment not enough; Insurtech filing surge to continue


Managing IP rounds up the latest news and analysis from in-house counsel in patent-focused businesses


US TERM bill is “blunt instrument” that would be disastrous say drug innovators

Proposed legislation in the US House of Representatives seeks to limit patent term extension for pharmaceutical products in a way that pharma innovators say would stifle innovation and not solve potential drug pricing problems. Read More...

SPC waiver: drug companies and patent offices start preparations

With the EU SPC Manufacturing Waiver due to come into force next week, innovators, generics and patent offices say that they are looking at which products might be affected and whether to charge notification fees. Read more...

Foreign businesses worried China’s Patent Law changes are too modest

In-house counsel say they would have preferred to have seen more robust changes in the fourth amendment to China’s Patent Law as well as better predictability of rulings. Read more...

Insurtech patent filings will grow as innovation becomes more important say insurance companies

With insurtech patents increasing by 40% in 2017, in-house counsel at Allstate, The Hartford and elsewhere say filings will continue to go up as they seek to become more customer-centric organisations. Read more...

more from across site and ros bottom lb

More from across our site

Civil society and industry representatives met in Geneva on Thursday, September 28 to discuss a potential expansion of the TRIPS waiver
Sources say the beta version of the USPTO’s new trademark search tool is a big improvement over the current system but that it isn’t perfect
Canadian counsel weigh in on the IP office’s decision to raise trademark filing fees in 2024 and how they’re preparing clients
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Shira Perlmutter, US Register of Copyrights, discussed the Copyright Office's role in forming generative AI policy during a House of Representatives hearing
The award marks one of the highest-ever damages received by a foreign company in a trademark infringement suit in China
Two orders denying public access to documents have reignited a debate over a lack of transparency at the new court
Rouse’s new chief of operations and the firm’s CEO tell Managing IP why they think private equity backing will help it conquer Europe
Brian Landry, partner at Saul Ewing, reveals how applicants can prosecute patent applications in the wake of the Federal Circuit's In re Cellect ruling
Ronelle Geldenhuys of Australia’s Foundry IP considers the implications complex computer technologies such as AI have on decision-making